LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR)
CUSIP: 514766104
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 37,508,353
- Total 13F shares
- 24,384,958
- Share change
- +1,613,218
- Total reported value
- $198,008,217
- Price per share
- $8.12
- Number of holders
- 84
- Value change
- +$13,339,387
- Number of buys
- 48
- Number of sells
- 34
Quarterly Holders Quick Answers
What is CUSIP 514766104?
CUSIP 514766104 identifies LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 514766104:
Top shareholders of LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WYNNEFIELD CAPITAL INC |
13F
|
Company |
13%
|
4,703,216
|
$33,110,640 | — | 31 Mar 2025 | |
| Legion Partners Asset Management, LLC |
13F
|
Company |
12%
|
4,431,823
|
$31,200,034 | — | 31 Mar 2025 | |
| 22NW, LP |
13F
|
Company |
4.7%
|
1,755,161
|
$29,820,465 | — | 31 Mar 2025 | |
| Greenhaven Road Investment Management, L.P. |
13F
13D/G
|
Company |
9.8%
from 13D/G
|
3,616,146
|
$25,457,668 | — | 31 Mar 2025 | |
| 22NW Fund, LP |
13D/G
|
— |
7.5%
|
2,975,398
|
$20,768,278 | -$9,716,865 | 27 May 2025 | |
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP I |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,703,216
|
$19,283,185 | — | 03 Oct 2024 | |
| 325 CAPITAL LLC |
13F
|
Company |
5.8%
|
2,162,466
|
$15,223,761 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
4.7%
|
1,764,919
|
$12,425,030 | — | 31 Mar 2025 | |
| David Capital Partners, LLC |
13D/G
|
— |
4.9%
|
1,803,000
|
$11,467,080 | $0 | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.1%
|
1,546,617
|
$10,888,184 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
750,498
|
$5,285,211 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.9%
|
728,511
|
$5,128,721 | — | 31 Mar 2025 | |
| DCF Advisers, LLC |
13F
|
Company |
1.3%
|
483,000
|
$3,400,320 | — | 31 Mar 2025 | |
| James G. Hall |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
276,096
|
$2,876,920 | — | 01 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
397,490
|
$2,798,330 | — | 31 Mar 2025 | |
| Aron R. English |
3/4/5
|
10%+ Owner |
0.7%
|
264,180
|
$1,881,965 | -$9,132,503 | 23 May 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.63%
|
235,131
|
$1,655,323 | — | 31 Mar 2025 | |
| John D. Morberg |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
125,617
|
$1,308,929 | — | 18 Jan 2024 | |
| Quinn Opportunity Partners LLC |
13F
|
Company |
0.41%
|
153,446
|
$1,080,260 | — | 31 Mar 2025 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.4%
|
151,700
|
$1,067,968 | — | 31 Mar 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.39%
|
145,900
|
$1,027,136 | — | 31 Mar 2025 | |
| Craig A. Barbarosh |
3/4/5
|
Director |
—
class O/S missing
|
88,073
|
$917,721 | — | 08 Jul 2024 | |
| Jeffrey L. Edwards |
3/4/5
|
Director |
—
class O/S missing
|
79,667
|
$830,130 | — | 08 Jul 2024 | |
| UBS Group AG |
13F
|
Company |
0.29%
|
110,217
|
$775,928 | — | 31 Mar 2025 | |
| Albert D. Bolles |
3/4/5
|
Chief Executive Officer |
—
class O/S missing
|
72,883
|
$759,441 | — | 23 May 2022 | |
| Raymond H. Diradoorian |
3/4/5
|
Director |
—
class O/S missing
|
69,978
|
$729,171 | — | 08 Jul 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.27%
|
100,813
|
$709,724 | — | 31 Mar 2025 | |
| Tonia L. Pankopf |
3/4/5
|
Director |
—
class O/S missing
|
59,599
|
$621,022 | — | 04 Jun 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.23%
|
87,998
|
$619,506 | — | 31 Mar 2025 | |
| Nathaniel Calloway |
3/4/5
|
Director |
—
class O/S missing
|
58,069
|
$605,079 | — | 08 Jul 2024 | |
| GAMCO INVESTORS, INC. ET AL |
13F
|
Company |
0.23%
|
84,500
|
$594,880 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.22%
|
83,663
|
$588,987 | — | 31 Mar 2025 | |
| Catherine A. Sohn |
3/4/5
|
Director |
—
class O/S missing
|
54,069
|
$563,399 | — | 04 Jun 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.21%
|
79,495
|
$559,645 | — | 31 Mar 2025 | |
| Alpha Wave Global, LP |
13F
|
Company |
0.19%
|
72,260
|
$508,710 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.18%
|
67,820
|
$477,453 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
61,800
|
$435,072 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.15%
|
55,407
|
$390,065 | — | 31 Mar 2025 | |
| Deborah D. Carosella |
3/4/5
|
Director |
—
class O/S missing
|
36,588
|
$381,247 | — | 04 Jun 2022 | |
| Diversified Trust Co |
13F
|
Company |
0.12%
|
46,062
|
$324,276 | — | 31 Mar 2025 | |
| Andrew Kenneth William Powell |
3/4/5
|
Director |
—
class O/S missing
|
27,477
|
$286,310 | — | 04 Jun 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.1%
|
37,256
|
$262,282 | — | 31 Mar 2025 | |
| Boston Partners |
13F
|
Company |
0.09%
|
34,175
|
$240,590 | — | 31 Mar 2025 | |
| Timothy P. Burgess |
3/4/5
|
Senior VP of Supply Chain |
—
mixed-class rows
|
30,000
mixed-class rows
|
$239,704 | — | 27 Jul 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.08%
|
30,523
|
$214,882 | — | 31 Mar 2025 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0.08%
|
30,233
|
$212,840 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.08%
|
28,837
|
$203,012 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.08%
|
28,828
|
$202,949 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
27,262
|
$191,925 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.07%
|
25,454
|
$179,196 | — | 31 Mar 2025 |
Institutional Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q2 2025
As of 30 Jun 2025,
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) was held by
84 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,384,958 shares.
The largest 10 holders included
WYNNEFIELD CAPITAL INC, Legion Partners Asset Management, LLC, Greenhaven Road Investment Management, L.P., 325 CAPITAL LLC, BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, GRIZZLYROCK CAPITAL, LLC, and STATE STREET CORP.
This page lists
85
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
85
Q2 2025 holders
84
Holder diff
-1
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.